In addition, even if our results of operations, financial condition and liquidity, and developments in the industry in which we operate are consistent with the forward-looking statements contained in such reports, those results or developments may not be indicative of results or developments in subsequent periods
[2] [5] Ozempic (semaglutide) and Mounjaro (tirzepatide) are FDA-approved for type 2 diabetes management, not weight loss, though they may be used off-label for this purpose
Carnipure guarantees 100 % pure L-carnitine and 0 % D-carnitine
Liver health Emerging evidence suggests that GLP-1s may have beneficial effects on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), conditions often associated with obesity and type 2 diabetes and more common in people with hypothyroidism
And as always, the patient's expectations should be calibrated to what the evidence actually supports
Kennedy has criticized proposals to allow government health plans to pay for costly GLP-1 drugs